Rare diseases
Investigational molecules
Locations
Study of mRNA-4157 and Pembrolizumab for Patients with Metastatic Melanoma
FranceStudy of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma
FranceVusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments
FranceStudy of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy
FranceStudy of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
FranceStudy of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels
FranceStudy Comparing Tepotinib to Standard Treatment for Patients with Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer
FranceStudy on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases
FranceStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceStudy on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma
FranceStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
FranceStudy on Chemotherapy for Patients with Resected Pancreatic Cancer Using FOLFIRINOX and Drug Combination
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
